Clinical Trial Update: SSGJ-707 in Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the investigational drug SSGJ-707 in advanced non-small cell lung cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SSGJ-707

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 3 | Status: RECRUITING